Greenwich Life Extends Lock-up of Directors and Officers to June 30, 2025
Greenwich LifeSciences Partners with GEICAM in Spain
STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the Company), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)